Medmira Inc. Stock
€0.047
Your prediction
Medmira Inc. Stock
Pros and Cons of Medmira Inc. in the next few years
Pros
Cons
Performance of Medmira Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Medmira Inc. | -2.110% | -4.124% | -6.061% | -4.124% | -28.462% | - | - |
Theralase Technologies Inc | - | -6.481% | -12.931% | -45.109% | -2.885% | -37.654% | -59.984% |
InVivo Therapeutics Holdings | -2.480% | 9.790% | -6.548% | -71.964% | -54.360% | -99.934% | -99.934% |
Atossa Genetics Inc | 1.950% | 11.232% | 17.850% | 21.464% | 30.499% | -65.889% | -67.201% |
News
![MedMira Announces the Hire of Vice President of Business Development](/assets/news/news5-af8c677c86bb4b693f58afef33877e6f798ff0d7e2b4fa69b6e89960549b5ee6.png)
MedMira Announces the Hire of Vice President of Business Development
Halifax, Nova Scotia, 30 April, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) is pleased to announce the expansion of their commercialisation team by welcoming Ms. Rene Bell to the
![MedMira gibt Einstellung eines Vizepräsidenten für Geschäftsentwicklung bekannt](/assets/news/news12-a6c8e663da6f66e4f8b76885d84b91bc276bfd92fd8727e9ade1f1d9f4df9b67.png)
MedMira gibt Einstellung eines Vizepräsidenten für Geschäftsentwicklung bekannt
Halifax, Nova Scotia, 30 April, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) is pleased to announce the expansion of their commercialisation team by welcoming Ms. Rene Bell to the
![MedMira Receives Canadian Patent for its Unique Quantitative Diagnostic System: https://www.irw-press.at/prcom/images/messages/2024/73936/14032024_EN_Medmira.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM0pVYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--be064bc1951f2403eb94dd4875ce66ddec3d0663/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/14032024_EN_Medmira.001.png?locale=us)
MedMira Receives Canadian Patent for its Unique Quantitative Diagnostic System
Halifax, Nova Scotia, March 13, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the receipt of a Canadian patent (number 2,949,634) for its new innovative and quantitative test